The Lancet. Rheumatology Mahil, S K, Bechman, K, Raharja, A, Domingo-Vila, C, Baudry, D, Brown, M A, Cope, A P, Dasandi, T, Graham, C, Khan, H, Lechmere, T, Malim, M H, Meynell, F, Pollock, E, Sychowska, K, Barker, J N, Norton, S, Galloway, J B, Doores, K J, Tree, T & Smith, C H 2022, ' Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression : a longitudinal cohort study ', The Lancet Rheumatology, vol. 4, no. 1, pp. e42-e52 . https://doi.org/10.1016/S2665-9913(21)00333-7